Labcorp (LH) Stock Forecast & Price Target

Q: What analysts cover Labcorp?

Labcorp has been rated by research analysts at Evercore , Robert W. Baird , and Weiss Ratings in the past 90 days.

$261.67 -3.48 (-1.31%)

Closing price 03:59 PM Eastern

Extended Trading

$261.94 +0.27 (+0.10%)

As of 07:50 PM Eastern

Compare

Labcorp - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 11 Analyst Ratings

Sell
0

Hold
3

Buy
8

Based on 11 Wall Street analysts who have issued ratings for Labcorp in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 3 have given a hold rating, and 8 have given a buy rating for LH.

Consensus Price Target

$308.00
17.71% Upside

According to the 11 analysts' twelve-month price targets for Labcorp, the average price target is $308.00. The highest price target for LH is $334.00, while the lowest price target for LH is $260.00. The average price target represents a forecasted upside of 17.71% from the current price of $261.67.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Labcorp and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LH Analyst Ratings Over Time

Type	Current Forecast 6/8/25 to 6/8/26	1 Month Ago 5/9/25 to 5/9/26	3 Months Ago 3/10/25 to 3/10/26	1 Year Ago 6/8/24 to 6/8/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$308.00	$308.00	$304.82	$272.92
Forecasted Upside	17.71% Upside	21.26% Upside	13.48% Upside	7.48% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Labcorp Stock vs. The Competition

Type	Labcorp	Medical Companies	Broader Market
Consensus Rating Score	2.73	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	17.71% Upside	683.48% Upside	16.08% Upside
News Sentiment Rating	Positive News See Recent LH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/8/2026	Weiss Ratings Not Rated		Reiterated Rating	Buy (B-)
5/1/2026	Robert W. Baird 3 of 5 stars	Eric Coldwell 2 of 5 stars	Set Target		$334.00	+30.77%
4/8/2026	Evercore 3 of 5 stars		Reiterated Rating	Outperform	$300.00	+14.07%
2/24/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$270.00 ➝ $300.00	+5.21%
2/18/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$319.00 ➝ $330.00	+17.64%
2/17/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
10/29/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$325.00 ➝ $320.00	+25.57%
10/17/2025	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$285.00 ➝ $320.00	+12.84%
10/14/2025	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$320.00	+14.51%
10/2/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Meehan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$275.00 ➝ $290.00	+3.81%
Get the Latest News and Ratings for LH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Labcorp and its competitors with MarketBeat's FREE daily newsletter.
7/10/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Morten Herholdt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$260.00	+2.70%
4/2/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$276.00	+18.64%
3/4/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ralph Giacobbe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$250.00 ➝ $300.00	+18.11%
2/6/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tycho Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$275.00 ➝ $290.00	+17.25%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$262.00 ➝ $271.00	+16.67%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$220.00 ➝ $230.00	-2.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:39 PM ET.

Should I Buy Labcorp Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 6, 2026. Please send any questions or comments about these Labcorp pros and cons to contact@marketbeat.com.

Labcorp
Bull Case

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

The company recently reported earnings per share of $4.25, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
Laboratory Co. of America Holdings has set its fiscal year 2026 guidance at an earnings per share range of 17.700-18.350, suggesting confidence in future profitability.
With a market capitalization of approximately $21.28 billion, the company is well-positioned in the market, providing stability and potential for long-term investment.
The current stock price is around $300, reflecting a positive market sentiment and potential for appreciation as the company continues to perform well.
The company has a relatively low dividend payout ratio of 25.51%, indicating that it retains a significant portion of its earnings for reinvestment, which could lead to future growth.

Labcorp
Bear Case

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

The price-to-earnings ratio of 22.98 may suggest that the stock is overvalued compared to its earnings, which could deter value-focused investors.
Despite recent positive earnings, the company has a beta of 0.90, indicating that it may be less volatile than the market, which could limit potential high returns for aggressive investors.
Analysts have mixed ratings, with some maintaining a "hold" rating, which may indicate uncertainty about the stock's future performance.
Recent revenue growth of 5.8% year-over-year may not be sufficient to meet the high expectations set by investors, leading to potential disappointment.
Institutional investors hold a significant majority of the stock, which could lead to volatility if large shareholders decide to sell their positions.

LH Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Labcorp is $308.00, with a high forecast of $334.00 and a low forecast of $260.00.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Labcorp in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" LH shares.

According to analysts, Labcorp's stock has a predicted upside of 17.71% based on their 12-month stock forecasts.

Labcorp has been rated by research analysts at Evercore, Robert W. Baird, and Weiss Ratings in the past 90 days.

Analysts like Labcorp more than other "medical" companies. The consensus rating for Labcorp is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how LH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Labcorp Recommendations

This page (NYSE:LH) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Labcorp (LH) Stock Forecast & Price Target